- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.98 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x CA: CALCIUM ION(Non-covalent)
- 4 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
FES.3: 8 residues within 4Å:- Chain A: Q.112, C.113, G.114, C.116, C.148, R.149, C.150, L.744
4 PLIP interactions:4 interactions with chain A,- Metal complexes: A:C.113, A:C.116, A:C.148, A:C.150
FES.4: 10 residues within 4Å:- Chain A: G.42, C.43, G.44, G.46, G.47, C.48, G.49, C.51, N.71, C.73
4 PLIP interactions:4 interactions with chain A,- Metal complexes: A:C.43, A:C.48, A:C.51, A:C.73
FES.23: 8 residues within 4Å:- Chain B: Q.112, C.113, G.114, C.116, C.148, R.149, C.150, L.744
4 PLIP interactions:4 interactions with chain B,- Metal complexes: B:C.113, B:C.116, B:C.148, B:C.150
FES.24: 10 residues within 4Å:- Chain B: G.42, C.43, G.44, G.46, G.47, C.48, G.49, C.51, N.71, C.73
4 PLIP interactions:4 interactions with chain B,- Metal complexes: B:C.43, B:C.48, B:C.51, B:C.73
- 2 x MTE: PHOSPHONIC ACIDMONO-(2-AMINO-5,6-DIMERCAPTO-4-OXO-3,7,8A,9,10,10A-HEXAHYDRO-4H-8-OXA-1,3,9,10-TETRAAZA-ANTHRACEN-7-YLMETHYL)ESTER(Non-covalent)
MTE.5: 19 residues within 4Å:- Chain A: Q.112, C.150, G.796, G.797, F.798, G.799, R.912, M.1038, G.1039, Q.1040, A.1078, A.1079, S.1080, V.1081, S.1082, Q.1194, G.1260, E.1261
- Ligands: MOS.6
14 PLIP interactions:14 interactions with chain A- Hydrogen bonds: A:Q.112, A:G.797, A:F.798, A:M.1038, A:Q.1040, A:S.1082, A:S.1082, A:S.1082, A:T.1083, A:Q.1194, A:Q.1194
- Water bridges: A:R.912, A:S.1080, A:T.1083
MTE.25: 19 residues within 4Å:- Chain B: Q.112, C.150, G.796, G.797, F.798, G.799, R.912, M.1038, G.1039, Q.1040, A.1078, A.1079, S.1080, V.1081, S.1082, Q.1194, G.1260, E.1261
- Ligands: MOS.26
13 PLIP interactions:13 interactions with chain B- Hydrogen bonds: B:Q.112, B:G.797, B:F.798, B:M.1038, B:Q.1040, B:S.1082, B:S.1082, B:S.1082, B:T.1083, B:Q.1194, B:Q.1194
- Water bridges: B:Q.112, B:R.912
- 2 x MOS: DIOXOTHIOMOLYBDENUM(VI) ION(Non-covalent)
MOS.6: 11 residues within 4Å:- Chain A: Q.767, F.798, G.799, E.802, A.910, F.911, R.912, A.1078, A.1079, E.1261
- Ligands: MTE.5
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Q.767, A:A.1079
MOS.26: 12 residues within 4Å:- Chain B: Q.767, F.798, G.799, E.802, A.910, F.911, R.912, T.1077, A.1078, A.1079, E.1261
- Ligands: MTE.25
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:Q.767, B:E.802, B:A.1079
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
FAD.7: 32 residues within 4Å:- Chain A: E.45, G.46, G.47, L.74, K.256, L.257, V.258, V.259, G.260, N.261, T.262, E.263, I.264, A.301, F.337, A.338, V.342, A.346, S.347, G.349, G.350, N.351, I.353, T.354, S.359, D.360, I.403, L.404, K.422, D.429, D.430
- Ligands: GOL.12
27 PLIP interactions:27 interactions with chain A- Hydrophobic interactions: A:L.74, A:A.338, A:V.342
- Hydrogen bonds: A:L.257, A:L.257, A:V.259, A:G.260, A:N.261, A:T.262, A:T.262, A:E.263, A:E.263, A:I.264, A:A.338, A:S.347, A:N.351, A:T.354, A:D.360, A:D.360, A:D.360, A:L.404, A:L.404
- Water bridges: A:S.347, A:T.354, A:K.422, A:A.432
- pi-Stacking: A:F.337
FAD.27: 33 residues within 4Å:- Chain B: E.45, G.46, G.47, L.74, K.256, L.257, V.258, V.259, G.260, N.261, T.262, E.263, I.264, A.301, W.336, F.337, A.338, V.342, A.346, S.347, G.349, G.350, N.351, I.353, T.354, S.359, D.360, I.403, L.404, K.422, D.429, D.430
- Ligands: GOL.37
26 PLIP interactions:26 interactions with chain B- Hydrophobic interactions: B:L.74, B:A.338, B:V.342
- Hydrogen bonds: B:K.256, B:L.257, B:V.259, B:G.260, B:N.261, B:T.262, B:E.263, B:E.263, B:E.263, B:I.264, B:A.338, B:S.347, B:N.351, B:D.360, B:D.360, B:L.404, B:L.404
- Water bridges: B:S.347, B:T.354, B:K.422, B:D.429, B:A.432
- pi-Stacking: B:F.337
- 2 x YSH: 1-[3-CYANO-4-(NEOPENTYLOXY)PHENYL]-1H-PYRAZOLE-4-CARBOXYLIC ACID(Non-covalent)
YSH.8: 16 residues within 4Å:- Chain A: L.648, N.768, K.771, E.802, L.873, S.876, R.880, F.914, S.1008, F.1009, T.1010, V.1011, F.1013, L.1014, P.1076, A.1079
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:L.873, A:L.873, A:V.1011, A:F.1013, A:L.1014
- Hydrogen bonds: A:N.768, A:K.771, A:T.1010
- Water bridges: A:A.1079, A:E.1261
- Salt bridges: A:R.880
- pi-Stacking: A:F.914, A:F.1009
YSH.28: 16 residues within 4Å:- Chain B: L.648, N.768, K.771, E.802, L.873, S.876, R.880, F.914, S.1008, F.1009, T.1010, V.1011, F.1013, L.1014, P.1076, A.1079
12 PLIP interactions:12 interactions with chain B- Hydrophobic interactions: B:L.873, B:L.873, B:V.1011, B:F.1013, B:L.1014
- Hydrogen bonds: B:N.768, B:T.1010
- Water bridges: B:A.1079, B:E.1261
- Salt bridges: B:R.880
- pi-Stacking: B:F.914, B:F.1009
- 21 x GOL: GLYCEROL(Non-functional Binders)
GOL.9: 7 residues within 4Å:- Chain A: F.549, K.994, E.1163, D.1165, D.1170, H.1171, K.1172
Ligand excluded by PLIPGOL.10: 8 residues within 4Å:- Chain A: E.480, Y.520, L.521, L.524, K.537, L.538, D.539, Y.542
Ligand excluded by PLIPGOL.11: 6 residues within 4Å:- Chain A: W.336, K.422, Q.423, R.427, F.549, D.1170
Ligand excluded by PLIPGOL.12: 6 residues within 4Å:- Chain A: E.45, I.266, I.431, S.1225
- Ligands: FAD.7, GOL.13
Ligand excluded by PLIPGOL.13: 7 residues within 4Å:- Chain A: E.45, I.266, F.270, N.830, R.1222, S.1225
- Ligands: GOL.12
Ligand excluded by PLIPGOL.14: 6 residues within 4Å:- Chain A: D.594, F.604, P.675, R.824, C.825, M.826
Ligand excluded by PLIPGOL.15: 8 residues within 4Å:- Chain A: E.759, N.785, R.786, I.787, L.788
- Chain B: L.1030, Y.1062, S.1064
Ligand excluded by PLIPGOL.16: 8 residues within 4Å:- Chain A: L.580, A.581, M.584, R.793, H.1043, V.1047, Y.1062, I.1063
Ligand excluded by PLIPGOL.17: 5 residues within 4Å:- Chain A: Q.561, G.574, S.1184, S.1185, P.1188
Ligand excluded by PLIPGOL.18: 9 residues within 4Å:- Chain A: C.662, G.664, H.665, I.666, R.804, I.835, N.869, S.906, S.907
Ligand excluded by PLIPGOL.19: 7 residues within 4Å:- Chain A: R.606, L.607, V.608, T.609, E.679, A.682, H.683
Ligand excluded by PLIPGOL.29: 6 residues within 4Å:- Chain B: L.521, L.524, K.537, L.538, D.539, Y.542
Ligand excluded by PLIPGOL.30: 7 residues within 4Å:- Chain B: F.549, K.994, E.1163, D.1165, D.1170, H.1171, K.1172
Ligand excluded by PLIPGOL.31: 7 residues within 4Å:- Chain B: W.336, K.422, Q.423, R.427, F.549, D.1170
- Ligands: GOL.38
Ligand excluded by PLIPGOL.32: 7 residues within 4Å:- Chain B: L.580, A.581, R.793, H.1043, V.1047, Y.1062, I.1063
Ligand excluded by PLIPGOL.33: 9 residues within 4Å:- Chain B: R.31, R.37, D.594, D.595, I.596, R.598, F.604, R.824
- Ligands: GOL.34
Ligand excluded by PLIPGOL.34: 6 residues within 4Å:- Chain B: D.594, F.604, P.675, R.824, M.826
- Ligands: GOL.33
Ligand excluded by PLIPGOL.35: 9 residues within 4Å:- Chain B: C.662, G.664, H.665, I.666, R.804, I.835, N.869, S.906, S.907
Ligand excluded by PLIPGOL.36: 6 residues within 4Å:- Chain B: E.45, I.266, F.270, K.271, S.1225
- Ligands: GOL.37
Ligand excluded by PLIPGOL.37: 5 residues within 4Å:- Chain B: I.266, I.431, S.1225
- Ligands: FAD.27, GOL.36
Ligand excluded by PLIPGOL.38: 10 residues within 4Å:- Chain B: E.332, R.335, W.336, F.421, K.422, K.518, L.548, F.549, T.1168
- Ligands: GOL.31
Ligand excluded by PLIP- 2 x ACY: ACETIC ACID(Non-functional Binders)
ACY.20: 9 residues within 4Å:- Chain A: R.839, H.840, I.877, T.909, A.910, F.911, F.914, G.915, Q.918
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:I.877
- Hydrogen bonds: A:H.840, A:T.909, A:G.915, A:Q.918
- Salt bridges: A:R.839, A:H.840
ACY.39: 9 residues within 4Å:- Chain B: R.839, H.840, I.877, T.909, A.910, F.911, F.914, G.915, Q.918
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:I.877, B:F.911
- Hydrogen bonds: B:H.840, B:T.909, B:G.915, B:Q.918
- Salt bridges: B:R.839, B:H.840
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fukunari, A. et al., Y-700 [1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-1H-pyrazole-4-carboxylic acid]: a potent xanthine oxidoreductase inhibitor with hepatic excretion. J.Pharmacol.Exp.Ther. (2004)
- Release Date
- 2004-12-21
- Peptides
- Xanthine dehydrogenase/oxidase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.98 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x CA: CALCIUM ION(Non-covalent)
- 4 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- 2 x MTE: PHOSPHONIC ACIDMONO-(2-AMINO-5,6-DIMERCAPTO-4-OXO-3,7,8A,9,10,10A-HEXAHYDRO-4H-8-OXA-1,3,9,10-TETRAAZA-ANTHRACEN-7-YLMETHYL)ESTER(Non-covalent)
- 2 x MOS: DIOXOTHIOMOLYBDENUM(VI) ION(Non-covalent)
- 2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 2 x YSH: 1-[3-CYANO-4-(NEOPENTYLOXY)PHENYL]-1H-PYRAZOLE-4-CARBOXYLIC ACID(Non-covalent)
- 21 x GOL: GLYCEROL(Non-functional Binders)
- 2 x ACY: ACETIC ACID(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fukunari, A. et al., Y-700 [1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-1H-pyrazole-4-carboxylic acid]: a potent xanthine oxidoreductase inhibitor with hepatic excretion. J.Pharmacol.Exp.Ther. (2004)
- Release Date
- 2004-12-21
- Peptides
- Xanthine dehydrogenase/oxidase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B